Pêne F, Fletcher G H
Cancer. 1976 Jun;37(6):2586-90. doi: 10.1002/1097-0142(197606)37:6<2586::aid-cncr2820370604>3.0.co;2-x.
From 1952 through 1973, 79 patients with the diagnosis of in situ carcinoma and seven with the diagnosis of leukoplakia and/or atypical hyperplasia were treated with irradiation. The staging system was the same as for the invasive squamous carcinomas. The irradiation techniques were also identical to those used for invasive squamous cell carcinomas. The failure rate for the T1 lesions was 11% and 26% for the T2 lesions--in the same range as the failure rates observed for the invasive squamous carcinomas. Only two of the 12 failures were on the initially involved cord. These two facts suggest that most of the failures were not recurrences but were new disease developing on the dysplastic epithelium. There was a delay in the appearance of failure for the in situ carcinomas as compared with that for the invasive squamous cell carcinomas of the supraglottic larynx. Seventy-six percent of the patients have a normal voice.
从1952年至1973年,79例原位癌患者以及7例白斑病和/或非典型增生患者接受了放射治疗。分期系统与浸润性鳞状细胞癌相同。放射治疗技术也与用于浸润性鳞状细胞癌的技术相同。T1病变的失败率为11%,T2病变为26%,与浸润性鳞状细胞癌观察到的失败率范围相同。12例失败病例中只有2例发生在最初受累的声带。这两个事实表明,大多数失败并非复发,而是发育异常的上皮组织上新发的疾病。与声门上喉浸润性鳞状细胞癌相比,原位癌失败的出现存在延迟。76%的患者声音正常。